Nicholas Williams

Director/Board Member at

Alderaan Biotechnology SAS

Health Technology

Consumer Services

Finance

Profile

Nicholas Williams is currently a Board Director at Alderaan Biotechnology SAS, a Non-Executive Director at Versanis Bio, Inc., and a Partner at Medicxi Ventures (Jersey) Ltd. He graduated from the University of Cardiff.

Nicholas Williams active positions

Companies	Position	Start
Medicxi Ventures (Jersey) Ltd. Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements.	Private Equity Analyst	-
Versanis Bio, Inc. Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company	Director/Board Member	-
Alderaan Biotechnology SAS Alderaan Biotechnology SAS BiotechnologyHealth Technology Operates as preclinical stage company for monoclonal antibodies development for the treatment of cancer	Director/Board Member	-

All active positions of Nicholas Williams

Training of Nicholas Williams

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nicholas Williams's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Cardiff University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Medicxi Ventures (Jersey) Ltd. Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements.	Finance
Alderaan Biotechnology SAS Alderaan Biotechnology SAS BiotechnologyHealth Technology Operates as preclinical stage company for monoclonal antibodies development for the treatment of cancer	Health Technology
Versanis Bio, Inc. Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company	Health Technology